Judith Weinstein compensation by year
PHIBRO ANIMAL HEALTH Summary Compensation Table · all 2 fiscal years held| Component | FY2025 | FY2026 |
|---|---|---|
| Salary | $500,000 | $500,000 |
| Bonus | $150,000 | $0 |
| Stock awards | $0 | $86,841 |
| Option awards | $0 | $0 |
| Non-equity incentive | $343,350 | $325,000 |
| Pension and deferred compensation | $2,876 | $7,988 |
| All other | $47,701 | $55,357 |
| Total | $1,043,927 | $975,186 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PHIBRO ANIMAL HEALTH CORP DEF 14A filed September 18, 2026, accession 0001104659-26-108939, and prior-year filings. Open the filing on EDGAR.
How this page was built: the PHIBRO ANIMAL HEALTH CORP filed document, accession 0001104659-26-108939. Every figure is read from that document and cited to the page and table it appears in. Filed September 18, 2026.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 3,447 | $108,236 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in PHIBRO ANIMAL HEALTH CORP's FY2026 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments PHIBRO ANIMAL HEALTH discloses, by trigger · FY2026| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Disability | $0 | $108,236 | $0 | $108,236 |
| Change in control and involuntary termination | $711,700 | $108,236 | $24,680 | $844,616 |
| Death | $0 | $108,236 | $0 | $108,236 |
| Involuntary termination without cause | $711,700 | $0 | $24,680 | $736,380 |
| Retirement | $0 | $0 | $0 | $197,358 |
| Change in control, no termination | $0 | $0 | $0 | $0 |
Per the Potential Payments Upon Termination or Change in Control table in PHIBRO ANIMAL HEALTH CORP's FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.
PHIBRO ANIMAL HEALTH’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Jack Bendheim | Chairman of the Board and Executive Chairman | $5,229,898 |
| Larry Miller | Chief Operating Officer | $2,500,619 |
| Glenn David | Chief Financial Officer | $1,333,722 |
| Daniel Bendheim | President and Chief Executive Officer | $1,120,094 |
| Judith Weinstein · this page | Senior Vice President, General Counsel and Corporate Secretary | $975,186 |
The full PHIBRO ANIMAL HEALTH compensation record
free company briefThis page is one person within PHIBRO ANIMAL HEALTH's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PHIBRO ANIMAL HEALTH's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.